CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 144 Insider Sale of Securities
- 4 Planned sale Chief R&D Officer sold 1,721 shares at an average $33.52 ($57,693)
- 4 Planned sale President & CEO sold 11,832 shares at an average $36.42 ($430,959)
- 144 Insider Sale of Securities
- 4 Planned sale Chief R&D Officer sold 485 shares at $30.10 ($14,599)
- 4 Planned sale President & CEO sold 1,500 shares at $30.16 ($45,240)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief R&D Officer sold 725 shares at $26.59 ($19,278)
- 4 Open-market sale Chief Legal Officer sold 676 shares at $26.59 ($17,975)
- 4 Open-market sale President & CEO sold 1,573 shares at $26.59 ($41,826)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
Page 6 of 100 · 1,982 filings